Nucleofection of DCs to Generate Multivirus-specific T Cells for Prevention or Treatment of Viral Infections in the Immunocompromised Host
Open Access
- 1 September 2009
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 17 (9), 1616-1625
- https://doi.org/10.1038/mt.2009.140
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Phase I Study of a Herpes Simplex Virus Type 2 (HSV-2) DNA Vaccine Administered to Healthy, HSV-2-Seronegative Adults by a Needle-Free Injection SystemClinical and Vaccine Immunology, 2008
- DNA vaccines: ready for prime time?Nature Reviews Genetics, 2008
- Exploiting Cytokine Secretion to Rapidly Produce Multivirus-specific T Cells for Adoptive ImmunotherapyJournal of Immunotherapy, 2008
- Phase 1 Trial of Intranodal Injection of a Melan-A/MART-1 DNA Plasmid Vaccine in Patients With Stage IV MelanomaJournal of Immunotherapy, 2008
- Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primatesJCI Insight, 2008
- Identification of Hexon-Specific CD4 and CD8 T-Cell Epitopes for Vaccine and ImmunotherapyJournal of Virology, 2008
- Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infectionBlood, 2007
- Ex Vivo Expansion and Prophylactic Infusion of CMV-pp65 Peptide-Specific Cytotoxic T-Lymphocytes following Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2007
- Safe adoptive transfer of virus‐specific T‐cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantationBritish Journal of Haematology, 2006
- Emerging viral infections after hematopoietic cell transplantationPediatric Transplantation, 2005